Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey


This study presents the findings of a national survey of physicians about their knowledge of biosimilar biological products as well as the impact of biological product naming conventions on prescriber choice.

Related Products

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Allison Kolbe, (202) 839-1508, Content will be updated pending the outcome of the Section 508 review.


"Biosimilar Survey" (pdf, 163.83Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®